Summary
Exelon Corporation (EXC) has filed an 8-K report on November 24, 2025, disclosing important developments regarding a consolidated stockholder derivative action. The company announced that the United States District Court for the Northern District of Illinois granted preliminary approval for a proposed settlement of this litigation, captioned In re Exelon Corporation Derivative Litigation. This settlement, which has been a subject of ongoing discussions and mediation involving the company's Special Litigation Committee and Independent Review Committee, marks a significant step towards resolving these legal proceedings. Investors should note that the full terms of the proposed settlement are detailed in the Stipulation and Agreement of Settlement, which is an exhibit to this filing. The company is also publishing a Notice of Pendency and Proposed Settlement of Consolidated Derivative Action, as mandated by the court's preliminary approval order. While this filing provides an update on the legal matter, it's important to understand that this information is furnished under Regulation FD and is not deemed "filed" for purposes of certain securities laws, nor does it constitute an admission of materiality.
Key Highlights
- 1Exelon Corporation (EXC) received preliminary court approval for a settlement of a consolidated stockholder derivative action.
- 2The litigation, "In re Exelon Corporation Derivative Litigation," is based in the Northern District of Illinois.
- 3The proposed settlement was reached through mediation involving the company's Special Litigation Committee and Independent Review Committee.
- 4The court's order granting preliminary approval was issued on November 18, 2025.
- 5Details of the settlement are available in Exhibit 99.2 (Stipulation and Agreement of Settlement).
- 6Exelon is required to publish a Notice of Pendency and Proposed Settlement of Consolidated Derivative Action (Exhibit 99.1).